NVOH.US Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged

- USD
No recent price
Total assets
3.97M
Expense ratio
-
Dividend yield
6.89%
1-year return
-8.73%
Holdings
1
Since
2025

Fund data as reported by the issuer, updated Nov 15, 2026. Total assets are in the fund's base currency.

What does NVOH.US invest in?

  • Mostly Non-US stocks (93.9%)
  • Largest sector: Healthcare (100.0%)
  • Largest region: Europe Developed (100.0%)
  • Top 3 holdings: 90.4% of the fund

Asset allocation

  • Non-US stocks 93.9%
  • Cash 6.2%

Top holdings

All holdings, sectors and regions

Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged performance

Sharpe ratio 0.00
This year
-10.73%
1 year
-8.73%
3 years
-
5 years
-

Volatility 48.6% over 1 year. High: expect large swings.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

NVOH.US price

Prices on the chart can differ slightly from the closing prices StockSummer shows.

About Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged

The series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts ("ADRs") of the Novo Nordisk A/S (B Shares) (the "Company"). The series will not invest directly in the company. The fund is non-diversified.

Full fund profile